Europe

ALS Survival Data Return to the Evidence Debate

MenB Vaccination Moves From Baby Schedule to Student Outbreak Control

Measles Deaths in England Expose the Cost of Missed Protection

Europe’s AMR Strategy Depends on the Lab Result Being Right

EMA backs first oral obesity GLP-1 as pills push treatment towards mass-market adoption

GSK’s Nuvalent Deal Turns Lung Cancer Precision Into a $10.6 Billion Access Race

Parkinson’s Research Takes Aim at Mitochondrial Failure

Europe: the EU Cardiovascular Health Plan is becoming the “cancer plan” moment for heart disease

A new Lp(a) threshold could reshape cardiovascular risk assessment
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
